Drug Information

Drug General Information
Drug ID
D03LVT
Former ID
DNC013886
Drug Name
SEMIPLENAMIDE B
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526859]
Structure
Download
2D MOL

3D MOL
Formula
C25H45NO3
Canonical SMILES
CCCCCCCCCCCCCC=CCCC=C(C)C(=O)NCCOC(=O)C
InChI
1S/C25H45NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-23(2)25(28)26-21-22-29-24(3)27/h16-17,20H,4-15,18-19,21-22H2,1-3H3,(H,26,28)/b17-16+,23-20+
InChIKey
QXKJTHBWYQHGEY-UEAIFQQQSA-N
PubChem Compound ID
10454085
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [526859]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 526859J Nat Prod. 2003 Oct;66(10):1364-8.Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
Ref 526859J Nat Prod. 2003 Oct;66(10):1364-8.Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.